[Nephrotic syndrome revealing malignant thymoma].
BACKGROUND
A well-established manifestation of neoplastic disease, nephrotic syndrome is infrequently associated with thymoma. Only 18 cases have been reported in the literature.


METHODS
A 65-year-old man and a 60-year-old woman were seen for nephrotic syndrome. Minimal change renal disease was observed in the first patient whose nephrotic syndrome was steroid resistant. The second patient had membranous glomerulopathy and pure red cell aplasia. In both cases, nephrotic syndrome revealed thymoma.


CONCLUSIONS
The histological lesions in 17 of the 18 biopsied cases reported in the literature were minimal change in 10, focal segmental glomerulonephritis in 4, proliferative glomerulonephritis in 2, and membranous glomerulopathy in only one. The outcome of the nephrotic syndrome was dependent on the success of the thymoma treatment. Some patients responded to steroid and immunosuppressive agents. Pure red cell aplasia is uncommon and prognosis is poor. It can be successfully treated with cyclosporin A as in our second case.
Schillinger
F
F
Services de Néphrologie et d'Hémodialyse des Centres Hospitaliers de Troyes.
Milcent
T
T
Wolf
C
C
Gulino
R
R
Montagnac
R
R
D000328:Adult; D000368:Aged; D001706:Biopsy; D005260:Female; D005921:Glomerulonephritis / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007668:Kidney / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009404:Nephrotic Syndrome / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D013256:Steroids / Q000627:therapeutic use; D013945:Thymoma / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy; D013953:Thymus Neoplasms / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy; D016896:Treatment Outcome
D007166:Immunosuppressive Agents; D013256:Steroids
Syndrome néphrotique révélant un thymome malin.